Defining the molecular pathology of pancreatic body and tail adenocarcinoma

Volume: 105, Issue: 2
Published: Jan 1, 2018
Abstract
Background: Pancreatic ductal adenocarcinoma (PDAC) remains a dismal disease, with very little improvement in survival over the past 50 years. Recent large-scale genomic studies have improved understanding of the genomic and transcriptomic landscape of the disease, yet very little is known about molecular heterogeneity according to tumour location in the pancreas; body and tail PDACs especially tend to have a significantly worse prognosis. The...
Paper Details
Title
Defining the molecular pathology of pancreatic body and tail adenocarcinoma
Published Date
Jan 1, 2018
Volume
105
Issue
2
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.